Johnson & Johnson (JNJ) Total Current Liabilities (2009 - 2026)

Johnson & Johnson has disclosed Total Current Liabilities across 18 years of filings, most recently posting $57.7 billion for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $57.7 billion, up 1.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $57.7 billion (up 1.43% YoY), and the FY2025 annual result was $54.1 billion, up 7.56% from the prior year.
• Total Current Liabilities came in at $57.7 billion for Q1 2026 at Johnson & Johnson, up from $54.1 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $60.4 billion in Q2 2023 to a low of $43.4 billion in Q2 2022.
• The 5-year median for Total Current Liabilities is $51.3 billion (2024), against an average of $51.0 billion.
• Across the five-year window, Total Current Liabilities surged 39.14% in 2023 and dropped 19.29% in 2024, its largest moves.
• Johnson & Johnson's Total Current Liabilities stood at $45.5 billion in 2022, then advanced by 1.62% to $46.3 billion in 2023, then climbed by 8.73% to $50.3 billion in 2024, then gained by 7.56% to $54.1 billion in 2025, then advanced by 6.63% to $57.7 billion in 2026.
• The last three Total Current Liabilities figures came in at $57.7 billion (Q1 2026), $54.1 billion (Q4 2025), and $50.9 billion (Q3 2025), per Business Quant data.